GSK GlaxoSmithKline PLC ADRs
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:GSK.
$43.99 -0.43 (-0.97%)
As of 05/27/2022 15:20:25 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
ADRsCategory3:
Large cap
GICS sector: Health Care
Industry: Drug Manufacturers—General
Index country: United Kingdom
Country of incorporation: United Kingdom
IPO date: 09/04/2001
Outstanding shares: 2,541,795,154
Average volume: 5,830,710
Market cap: $114,304,528,075
Current dividend yield: 3.59%
All SEC filings:
SEC Edgar Online
Annual filings:
20-F
Sedol: 2374112
Valuation (See tab for details)
PE ratio: 17.49
PB ratio: 6.90
PS ratio: 2.49
Return on equity: 31.60%
Net income %: 14.02%